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ABSTRACT: We report a rapid “sample-to-answer” platform
that can be used for the quantitative monitoring of genetic
biomarkers within communities through the analysis of
wastewater. The assay is based on the loop-mediated
isothermal ampliﬁcation (LAMP) of nucleic acid biomarkers
and shows for the ﬁrst time the ability to rapidly quantify
human-speciﬁc mitochondrial DNA (mtDNA) from raw
untreated wastewater samples. mtDNA provides a model
population biomarker associated with carcinogenesis including
breast, renal and gastric cancers. To enable a sample-to-answer,
ﬁeld-based technology, we integrated a ﬁlter to remove solid impurities and perform DNA extraction and enrichment into a low
cost lateral ﬂow-based test. We demonstrated mtDNA detection over seven consecutive days, achieving a limit of detection of 40
copies of human genomic DNA per reaction volume. The assay can be performed at the site of sample collection, with minimal
user intervention, yielding results within 45 min and providing a method to monitor public health from wastewater.
Wastewater-based epidemiology has recently been shownto be an innovative and promising tool for the
estimation of community-wide drug,1,2 alcohol,3 and tobacco
use,4 as well as for the monitoring of oxidative stress biomarkers
such as F2-isoprostanes.5 Generally, drug residues and their
metabolites, or other biomarkers excreted by humans in a given
area (e.g., a city) pool within urban wastewater treatments
plants, from which samples can be collected and analyzed.
When compared with conventional population survey
methods,2 this approach oﬀers a near real-time and cost-
eﬀective evaluation of community-wide diseases (such as
cancer) or behaviors (such as drug-abuse), with the potential
to inﬂuence local, regional, and national policy.
This research ﬁeld holds great promise for the monitoring of
noncommunicable diseases (e.g., diabetes, cardiovascular
disease) as well as infectious diseases (e.g., sexually transmitted
infections) by providing a means to assess the levels of speciﬁc
disease biomarkers in wastewater.6 The technology has the
potential to provide an early warning sensing system that could,
in future, enable government agencies to deliver eﬀective
interventions based on prevalence.7
In order to estimate the public health status using these
methods, wastewater-based epidemiology requires human and
disease-speciﬁc biomarkers. The criteria for such candidate
biomarkers have been outlined previously.8 Brieﬂy, they should
be excreted in bodily ﬂuids predictably, as well as being
detectable and stable in wastewater. Such biomarker proxies
must also be unique to humans, and of low variance in the per
capita rate of daily excretion. Accordingly, DNA biomarkers are
prime candidates8,9 due to their stability,10 and as such,
environmental biomarkers potentially outperform metabolites
as they are more persistent (e.g., ecgonine methylester, a
metabolite of cocaine, shows 20% degradation after 12 h
storage).11
DNA is constantly excreted by humans and can be quantiﬁed
speciﬁcally, using particular DNA sequences as the biomarker.
The change of DNA sequence and structure via processes, such
as damage, repair, and mutation, might also provide more
subtle indications of the evolution of disease at population
level.8,12
In general, the extent of the knowledge gained will be subject
to the number of individuals carrying the disease and the
sensitivity of the analytical approaches used to identify and
quantify the biomarkers. These characteristics combine to make
it a population biomarker of choice.8,12
The mitochondrial genome is ∼16.5 kb in size and is present
in multiple copies in individual mitochondria. It is used as a
biomarker in a number of cancers including breast, renal and
gastric cancers.13 We recently proposed the use of community
sewage sensors as rapid and inexpensive alternatives to classical
analytical methods for the detection of sewage biomarkers.7 We
have previously also demonstrated that community sewage
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sensors are able to detect a wide range of markers (e.g., prostate
speciﬁc antigen14 and illicit drugs such as cocaine15). In a proof-
of-concept study, we showed that human-speciﬁc mtDNA
could be detected in sewage with an electrochemical DNA
sensor by using a ferrocenyl DNA intercalator as a redox
marker.9 However, the limitations of aﬃnity-based probe
sensors coupled with the complexity of the sewage matrix
require the development of an ampliﬁcation strategy to improve
the assay sensitivity to achieve the on-site monitoring.
Recently, loop-mediated isothermal ampliﬁcation (LAMP)
has emerged as a promising technique for the ampliﬁcation of a
wide spectrum of targets.16 Compared to gold-standard
techniques such as polymerase chain reaction (PCR), which
require precise temperature control during thermocycling,
LAMP provides a simple, rapid, speciﬁc, and cost-eﬀective
ampliﬁcation method.17 Additionally, LAMP has been coupled
with microﬂuidic sample preparation,18 capillary platforms,19,20
and paper devices,21 demonstrating its capabilities within a
point-of-care test.
In this paper, we now demonstrate a portable LAMP assay to
detect human-speciﬁc mtDNA in wastewater, as a population
biomarker, with the potential to monitor public health. We
demonstrate that the extraction of DNA from wastewater using
a commercial magnetic bead methodology,22 can be performed
in the ﬁeld, without using central laboratory facilities.
The assay was performed in a portable vacuum ﬂask ﬁlled
with hot water (e.g., a thermos), providing the required
temperature for the reaction (60 °C−64 °C) for over 45 min.19
At the end of the reaction, the amplicon produced was
transferred to a lateral ﬂow device to be read visually (Scheme
1). The working principle of the commercial lateral ﬂow device,
as previously published,23 is illustrated in Figure S1 and detailed
in the Materials and Methods. The entire assay, from the
sample to the answer, is completed within ∼45 min.
■ MATERIALS AND METHODS
Reagents. The Nalgene 25 mm syringe ﬁlters (nylon
membrane - pore size of 0.45 μm) were purchased from
Thermo Scientiﬁc. Gsp SSD DNA polymerase (large frag-
ment), MgSO4, and betaine were from OptiGene Ltd. (U.K.).
EvaGreen was from Biotium (U.K.). All the primers were
synthesized by Euroﬁns (U.K.; Table S2). SYBR Gold Nucleic
Acid Gel Stain was from Life Technologies (U.K.). The lateral
ﬂow device for LAMP ampliﬁcation product detection were
provided by Ustar Biotech Co., Ltd. (Hangzhou, China). The
MagaZorb DNA Mini-Prep kit, mineral oil (CAS Number
8042−47−5), deoxy-ribonucleoside triphosphates (dNTPs),
and other reagents were from Sigma-Aldrich (U.K.).
Wastewater Samples. Daily raw wastewater samples were
collected from a local wastewater treatment plant in South-
West England in a week-long sampling campaign. Samples were
tested and also frozen for retrospective analysis. The waste-
water sample was ﬁltered using a 60-ml syringe (0.45 μm pore-
sized membrane) and lysed chemically before magnetic
extraction and LAMP.
LAMP Assay. The speciﬁc primer set for the LAMP
reaction was designed to amplify the human mitochondrial
DNA (mtDNA) sequence (Table S1), gene AY972053. Primers
were tested for hybrids and hairpin structures using the
Integrated DNA Technologies design tools (http://eu.idtdna.
com/pages/scitools). The optimization of detection parameters
and the sensitivity of the LAMP assay were performed on a real
time PCR machine (ABI 7500 Fast real-time PCR, Thermo
Fisher Scientiﬁc, U.K.) at 63 °C. The LAMP amplicon was
analyzed on a 1% (w/v) agarose gel in TAE 1× buﬀer (pH 8)
and the image was recorded by a Bio-Rad reader.
For the lateral ﬂow device based LAMP amplicon detection,
the loop primers (MT LPF and MT PLB) were labeled at their
5′ ends with biotin and ﬂuorescein isothiocyanate (FITC),
respectively, as reported in.23 The amplicon of LAMP was
transferred with a pipet to the sample pad of the lateral ﬂow
device, for detection. A positive test was indicated by the
presence of two red lines, one assigned to the target sample and
another corresponding to the control, which conﬁrms if the test
is valid. A negative test was indicated with a single red line. If
there was no red line from the control, the test was regarded as
invalid.
After optimization, we used the following composition for
the LAMP mix: a 20 μL real-time LAMP mix solution was
composed of 0.8 μM inner primers (FIP and BIP), 0.6 μM of
the loop primers (LFR and LRP), 0.1 μM of bumper primers
(F3 and B3), 1.25 μM EvaGreen, 0.4 Unit of Gsp SSD DNA
polymerase, 0.4 mM of each dNTPs, 4.0 mM of MgSO4, 50
mM Tris-HCl (pH 8.1), 30 mM KCl, 30 mM (NH4)2SO4, 0.1%
Triton X-100, and 1 M of betaine. A total of 20 μL of mineral
oil was introduced to cover the LAMP solution to prevent the
evaporation during the incubation.
Extraction and Characterization of DNA. The whole
process contained four steps: cell concentration, DNA
extraction with MagaZorb reagents, DNA isothermal ampliﬁ-
cation in a vacuum ﬂask ﬁlled with hot water (using a
thermometer to check temperature when required), and lateral
follow devices for amplicon detection. The human genomic
Scheme 1. Illustration of the Extraction and Detection of Genomic Population Biomarkers in the Field with LAMP- Lateral
Flow Device
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DNA from the cultured cell was isolated according to the
manufacturer’s manual (DNeasy Kit (Qiagen)), and then
quantiﬁed with a NanoDrop 2000 Spectrophotometer
(Thermo Fisher Scientiﬁc, U.S.).
The extraction and test process were as follows: 40 mL water
sample was passed through a ﬁlter (0.45 μm pore size) using a
syringe. Cells and other coarse material was concentrated by
the ﬁlter. After the addition of 400 μL of lysis buﬀer in the
syringe, the ﬁltered water sample was incubated at room
temperature for 10 min for DNA release. The released DNA
(400 μL) was eluted into a PCR tube with the syringe and
mixed with MagaZorb reagent for DNA puriﬁcation. Finally, 1
μL of eluted DNA (after concentration with magnetic beads)
was ampliﬁed in a LAMP reaction. The LAMP reaction was
incubated within the thermos with a starting temperature of 64
°C, for 45 min, and the amplicon was detected with the lateral
ﬂow device visually.
Lateral Flow Assay. After ampliﬁcation, 10 μL of
amplicons were pipetted onto the lateral ﬂow device, followed
by 100 μL of testing buﬀer (saline sodium citrate (SSC) 2×,
Sigma, U.K.). The results can be read visually as shown in
Figure 1. The whole testing process takes less than 2 min.
Figure S1 also illustrates the working principle of the lateral
ﬂow device for the speciﬁc detection of mtDNA amplicons.
Brieﬂy, if the target was present in the sample and as the
speciﬁc LAMP reaction took place, amplicons were generated
with both biotin and FITC-labeled primers, as a complex
bearing two ligands. When this complex was ﬂowed through
the lateral ﬂow device containing anti-FITC antibodies and
immobilized streptavidin (coated with colored nanoparticles) in
the test and control lines, respectively, the two ligands were
speciﬁcally captured (Figure S1A). This generated two red lines
as a positive result. However, if there was no speciﬁc
ampliﬁcation, only a biotin−streptavidin conjugation took
place on the control line, showing one red line as a negative
result (Figure S1B).
■ RESULTS AND DISCUSSION
To achieve an accurate and sensitive assay, we optimized the
concentration of primers using real-time LAMP (details in the
SI). The vacuum ﬂask maintained the reaction temperature in a
range between 64.5 and 60.0 °C over 45 min (Figure S2),
which enabled the LAMP reaction to run successfully (Figure
1).
Serially diluted human genomic DNA with concentrations
from 12 to 0.12 ng μL−1 in Tris buﬀer (0.1 M, pH 8.0) were
processed through the system, to evaluate the analytical
performance (sensitivity and accuracy). Two groups of
reactions were performed; one group (lanes 1−4) incubated
at 63 °C using a real time PCR thermocycler (ABI 7500 Fast
System, Thermo), enabling precise temperature control; the
others (lanes 5−8) were incubated in a thermos that contains
about 50 mL of hot water at 64 °C. After incubation, the
ampliﬁcation products were detected by the lateral ﬂow device,
following the manufacturers’ instructions.23 A positive test was
indicated by the presence of two red lines: one assigned to the
target sample and another corresponding to the control that
conﬁrms that the test is valid. Results (Figure 1A) show no
diﬀerence between the two heating methodology. The
amplicons from the lowest target concentration (0.12 ng
μL−1) were also evaluated with an agarose electrophoresis gel
(Figure 1B), which conﬁrmed the similarity of the ampliﬁcation
and thus the compatibility of thermos-based technique for
LAMP ampliﬁcation.19
Figure 1C shows the results of the real-time LAMP
ampliﬁcation (using the ﬂuorescent dye EvaGreen as a
reporter). As the concentration of target DNA increased, the
exponential increase in the ﬂuorescence intensity started earlier.
The sensitivity reached 40 copies of human genomic DNA per
reaction, up to 10-fold better than reported real-time PCR
techniques on similar environmental samples.24 The LAMP
assay permits linear interrogation of mtDNA level in the range
from 0.012 ng μL−1 to 12 ng μL−1 (40 to 40000 copies of
human genomic DNA per reaction, Figure 1C, inset), thus,
providing a route for quantiﬁcation of the initial target DNA.
To evaluate the performance of the assay for wastewater
samples, we ﬁrst detected mtDNA in tap water spiked with
cultured human cells MG63 (osteosarcoma, as a model of a
cancer cell containing human-speciﬁc mtDNA, gene
AY972053) with an initial concentration of 2.5 × 106 cells
ml−1. The cells were spiked into 40 mL tap water and serially
diluted to evaluate the dose response for the detection of
Figure 1. Evaluation of feasibility and analytical performance of the
lateral ﬂow device for LAMP assay: (A) Image of the lateral ﬂow
device for the detection of LAMP reactions with serially diluted target
concentrations using the thermos and diﬀerent incubation conditions.
1−4 were incubated at 63 °C, while 5−8 were incubated in the
thermos; 1/5, 12 ng μL−1; 2/6, 1.2 ng μL−1; 3/7, 0.12 ng μL−1; 4/8,
negative. (B) Agarose gel image of the LAMP amplicons: Lane 1,
negative control (DNA-free water); Lane 2, 0.12 ng μL−1 target
processed in the ABI thermocycler; Lane 3, 0.12 ng μL−1 target
processed in the vacuum ﬂask (see Materials and Methods and SI for
details). (C). Real-time LAMP assay for 10× dilution series of target
concentrations; 1, 12 ng μL−1; 2, 1.2 ng μL−1; 3, 0.12 ng μL−1; 4, 0.012
ng μL−1; 5, 0.0012 ng μL−1; 6, negative control (no target DNA). The
inset is threshold time, Tt (deﬁned as the time corresponding to 50%
of the maximum ﬂuorescence intensity) as a function of target
concentration.19 Data is the average from three independent
measurements. Error bars are the standard deviation around the
mean (n = 3). The data was ﬁtted with linear regression (Figure 3C,
inset; R2 = 0.99).
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mtDNA with lateral ﬂow devices (Figure 2A), after extraction
(using a syringe; details in SI) and ampliﬁcation. Results show
that we were able to detect as low as 10 cells mL−1, comparable
to the results from the real-time assay (Figure 2B).
We validated this new platform for application in the ﬁeld,
using wastewater samples collected consecutively over 7 days
from a treatment plant in South-West England (Figure 3A).
The assays were also run on the real-time platform to quantify
the amount of DNA. The mean threshold time of the real-time
LAMP (p < 0.05) with the concentration of mtDNA in sewage
decreased with increasing the ﬂow rate of sewage but the total
amount of human-speciﬁc mtDNA in sewage did not vary
throughout the week. This can be understood from the fact that
the content of mtDNA shed by the local population is expected
to be correlated to the size of the population, which may not be
expected to vary signiﬁcantly over short periods of time
(although it is acknowledged at weekends and in holidays,
urban populations can vary). The content of mtDNA shed by
the local population will be inversely dependent on rainfall
(which increases total volume of runoﬀ above the levels of
wastewater generated by the population).
The results of the lateral ﬂow device analysis (read visually to
allow for ﬁeld testing, at the wastewater treatment plant) are in
close agreement with those from real-time LAMP. In addition,
we show that this technique can quantify the mtDNA in
wastewater, Figure 1C, a capability that could enable baselines
to be established for certain diseases (providing a method for
the recording of changes in public health status and the
epidemiology of diseases and their control). Such testing could
be performed in the ﬁeld with a portable machine for
isothermal assay (e.g., Optigene, U.K.). One potential
limitation is that the test is reliant on the availability of a
source of hot water (for the LAMP cycling). Examples of how
this constraint could be overcome involve using a range of
diﬀerent technologies, depending on the location where the
assay is to be performed, and may range from using a battery-
operated heater25 to exothermic chemical reactions26 and solar
ovens.27
One long-term aim is to develop a sensitive and portable
device for on-site monitoring of public health biomarkers. The
LAMP assay can overcome the challenges involved in rapidly
detecting low levels of human genome in wastewater, that
conventional aﬃnity-based biosensors have been shown to have
diﬃculties in delivering. In addition, as a sample-to-answer
portable technology, the technique can be implemented on-site
and does not involve sample transportation and storage (which
can potentially result in sample contamination and degrada-
tion).
Figure 2. Lateral ﬂow device for the detection of mtDNA in tap water spiked with cultured cells. The mtDNA was detected with the lateral ﬂow
device from tap water spiked with diﬀerent concentrations of cultured human cells: (A) Image of the lateral ﬂow device used for the detection of 10-
fold serial dilutions of cultured human cells spiked in tap water (1−6): 1, 105 cells mL−1; 2, 104 cells mL−1; 3, 103 cells mL−1; 4, 102 cells mL−1; 5, 10
cells mL−1; 6, 1 cell mL−1; 7, tap water; 8, ddH2O as a negative control. (B) Analytical sensitivity of real-time LAMP (samples 1 to 8 as in A). The
higher background signal observed (samples 6−8), compared with samples 5−6 in Figure 1C, is likely due to the accumulation of signal from the
nonspeciﬁc interaction between dyes and DNA molecules, potentially promoted by the impurities of the spiked cultured cells. The inset presents a
linear ﬁt for measurements of threshold time Tt for samples 1−5 (R2 = 0.99).
Figure 3. Lateral ﬂow device for the detection of mtDNA in raw wastewater: (A) image of the lateral ﬂow device results from the detection of
mtDNA in wastewater from 7 consecutive days, incubated in a thermos as described; (B) concentration of mtDNA in wastewater using real-time
LAMP to quantify it, as a function of the ﬂow rate of wastewater treatment plant.
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■ CONCLUSION
In summary, we have developed a cost-eﬀective and easy-to-use
isothermal sensing device for the identiﬁcation of population
biomarkers with the potential for monitoring public health. We
designed and demonstrated a LAMP assay for the detection of
human speciﬁc mtDNA in wastewater, a potential population
biomarker associated with cancer. The LAMP assay is able to
detect as low as 40 copies of mtDNA from human genomic
DNA, with a dynamic range from 40 copies to 40000 copies per
reaction. The sensing platform uses a lateral ﬂow device for
direct visual readout, allowing for the monitoring of population
biomarkers in resource-constrained areas, as a point-of-care test.
In addition, this device can be used with minimal user
intervention, as a generic platform for a range of nucleic acids.
In the future we will combine the data with the dynamics of
population and rainfall parameters utilized in wastewater-based
epidemiology (e.g., ﬂuctuations in population size, other public
health biomarkers, and runoﬀ water) to achieve a compre-
hensive study in which the rapid sensing platform will facilitate
monitoring with a strong potential to achieve a real-time study.
Crucially, this device may enable the development of early
warning sensing systems for public health agencies to initiate
eﬀective early interventions in disease control, as well as the
collection of quantitative epidemiological evidence to study
disease control (including, e.g., social interventions).
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